Market Place
Sourcing Support
All News #Library
Biomarin Pharmaceuticals`s Voxzogo Approved in Canada
21 Jan 2026 //
HEALTH CANADA
BioMarin Pharm`s Pegvaliase-pqpz BLA Receives Approval in US
20 Nov 2025 //
FDA
BioMarin`s Biologic Naglazyme (Galsufase) Receives Approval in US
12 Sep 2024 //
FDA
BioMarin Biologic Brineura (Cerliponase Alfa) Receives Suppl Approvals in US
24 Jul 2024 //
FDA
BioMarin Biologic Naglazyme (Galsulfase) Receives Suppl Approvals in US
10 Jul 2024 //
FDA
Biomarin`s Biologic Aldurazyme (laronidase) Receives Approval in the U.S.
14 Dec 2023 //
FDA
BioMarin`s Biologic Palynziq (pegvaliase) Receives Approval in the U.S.
09 Dec 2023 //
FDA
BioMarin`s Voxzogo (vosoritide) Receives Approval in Europe
26 Aug 2021 //
EMA
Biomarin Pharm`s Biological Pegvaliase-Pqpz Receives Approval In US
08 Oct 2020 //
FDA
Biomarin Pharm’s Naglazym (galsulfase) Receives Supplemental Approval In US
18 Dec 2019 //
FDA
BioMarin`s Aldurazyme (laronidase) Receives Supplemental Approval in US
04 Dec 2019 //
FDA
BioMarin`s Vimizim (elosulfase alfa) Receives Supplemental Approval in US
04 Dec 2019 //
FDA
Biomarin`s Biological Cerliponase Alfa Receives Supplemental Approval in US
12 Dec 2018 //
FDA
Biomarin’s Brineura (Cerliponase Alfa) Receives Approval In Europe
22 Jun 2017 //
EMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.